Peapack-Gladstone Financial Corp’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $310K | Buy |
1,691
+3
| +0.2% | +$553 | ﹤0.01% | 576 |
|
|
2025
Q4 | $297K | Sell |
1,688
-180
| -10% | -$29.4K | ﹤0.01% | 579 |
|
|
2025
Q3 | $262K | Buy |
1,868
+22
| +1% | +$2.97K | ﹤0.01% | 608 |
|
|
2025
Q2 | $232K | Buy |
1,846
+3
| +0.2% | +$374 | ﹤0.01% | 604 |
|
|
2025
Q1 | $252K | Buy |
1,843
+25
| +1% | +$3.57K | ﹤0.01% | 590 |
|
|
2024
Q4 | $278K | Buy |
1,818
+15
| +0.8% | +$2.53K | ﹤0.01% | 579 |
|
|
2024
Q3 | $349K | Sell |
1,803
-82
| -4% | -$17.2K | 0.01% | 551 |
|
|
2024
Q2 | $437K | Buy |
1,885
+1
| +0.1% | +$217 | 0.01% | 495 |
|
|
2024
Q1 | $406K | Sell |
1,884
-929
| -33% | -$218K | 0.01% | 516 |
|
|
2023
Q4 | $728K | Sell |
2,813
-143
| -5% | -$35.1K | 0.01% | 427 |
|
|
2023
Q3 | $759K | Sell |
2,956
-190
| -6% | -$50.8K | 0.01% | 418 |
|
|
2023
Q2 | $895K | Buy |
3,146
+75
| +2% | +$22.3K | 0.02% | 406 |
|
|
2023
Q1 | $858K | Sell |
3,071
-25
| -0.8% | -$6.92K | 0.02% | 404 |
|
|
2022
Q4 | $857K | Sell |
3,096
-441
| -12% | -$125K | 0.02% | 394 |
|
|
2022
Q3 | $945K | Buy |
3,537
+283
| +9% | +$60.1K | 0.02% | 373 |
|
|
2022
Q2 | $664K | Sell |
3,254
-115
| -3% | -$23.5K | 0.02% | 403 |
|
|
2022
Q1 | $709K | Sell |
3,369
-110
| -3% | -$23.9K | 0.01% | 414 |
|
|
2021
Q4 | $835K | Buy |
3,479
+45
| +1% | +$11.6K | 0.02% | 408 |
|
|
2021
Q3 | $972K | Sell |
3,434
-308
| -8% | -$101K | 0.02% | 373 |
|
|
2021
Q2 | $1.3M | Sell |
3,742
-24
| -0.6% | -$7.27K | 0.03% | 297 |
|
|
2021
Q1 | $1.05M | Buy |
3,766
+1,205
| +47% | +$325K | 0.03% | 312 |
|
|
2020
Q4 | $627K | Sell |
2,561
-93
| -4% | -$24K | 0.02% | 291 |
|
|
2020
Q3 | $753K | Hold |
2,654
| – | – | 0.03% | 246 |
|
|
2020
Q2 | $710K | Sell |
2,654
-26
| -1% | -$7.82K | 0.03% | 251 |
|
|
2020
Q1 | $848K | Sell |
2,680
-57
| -2% | -$17.3K | 0.04% | 218 |
|
|
2019
Q4 | $812K | Buy |
2,737
+39
| +1% | +$10.8K | 0.03% | 216 |
|
|
2019
Q3 | $628K | Sell |
2,698
-336
| -11% | -$78.2K | 0.03% | 238 |
|
|
2019
Q2 | $710K | Buy |
3,034
+220
| +8% | +$50.8K | 0.03% | 230 |
|
|
2019
Q1 | $665K | Sell |
2,814
-71
| -2% | -$22.4K | 0.03% | 225 |
|
|
2018
Q4 | $868K | Buy |
2,885
+31
| +1% | +$9.89K | 0.04% | 190 |
|
|
2018
Q3 | $1.01M | Buy |
2,854
+44
| +2% | +$15.1K | 0.05% | 186 |
|
|
2018
Q2 | $816K | Sell |
2,810
-159
| -5% | -$44.7K | 0.04% | 192 |
|
|
2018
Q1 | $813K | Hold |
2,969
| – | – | 0.04% | 189 |
|
|
2017
Q4 | $946K | Buy |
2,969
+188
| +7% | +$60.3K | 0.05% | 179 |
|
|
2017
Q3 | $871K | Hold |
2,781
| – | – | 0.05% | 183 |
|
|
2017
Q2 | $755K | Sell |
2,781
-83
| -3% | -$21.9K | 0.05% | 190 |
|
|
2017
Q1 | $783K | Buy |
2,864
+32
| +1% | +$9.05K | 0.05% | 184 |
|
|
2016
Q4 | $803K | Sell |
2,832
-25
| -0.9% | -$7.41K | 0.05% | 176 |
|
|
2016
Q3 | $894K | Hold |
2,857
| – | – | 0.06% | 172 |
|
|
2016
Q2 | $691K | Sell |
2,857
-75
| -3% | -$19.8K | 0.05% | 181 |
|
|
2016
Q1 | $763K | Sell |
2,932
-63
| -2% | -$16.6K | 0.05% | 176 |
|
|
2015
Q4 | $918K | Sell |
2,995
-40
| -1% | -$11.5K | 0.06% | 170 |
|
|
2015
Q3 | $886K | Hold |
3,035
| – | – | 0.07% | 171 |
|
|
2015
Q2 | $1.23M | Sell |
3,035
-45
| -1% | -$18.1K | 0.09% | 159 |
|
|
2015
Q1 | $1.3M | Buy |
3,080
+42
| +1% | +$16.6K | 0.09% | 155 |
|
|
2014
Q4 | $1.03M | Buy |
3,038
+250
| +9% | +$80.9K | 0.07% | 165 |
|
|
2014
Q3 | $922K | Buy |
2,788
+145
| +5% | +$47.8K | 0.07% | 166 |
|
|
2014
Q2 | $833K | Buy |
2,643
+23
| +0.9% | +$6.92K | 0.06% | 172 |
|
|
2014
Q1 | $801K | Buy |
2,620
+86
| +3% | +$27.3K | 0.06% | 170 |
|
|
2013
Q4 | $708K | Sell |
2,534
-15
| -0.6% | -$3.88K | 0.06% | 176 |
|
|
2013
Q3 | $614K | Sell |
2,549
-500
| -16% | -$112K | 0.05% | 179 |
|
|
2013
Q2 | $656K | Buy |
+3,049
| New | +$652K | 0.06% | 172 |
|
Other funds holding BIIB
VCM
VPM
Peapack-Gladstone Financial Corp's BIIB Position: Q1 2026 in Review
Peapack-Gladstone Financial Corp increased its Biogen (BIIB) stake by 0.18% in Q1 2026, buying an estimated $553 and bringing the position to 1,691 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #576.
Peapack-Gladstone Financial Corp first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.3M in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Peapack-Gladstone Financial Corp held 1,691 shares of Biogen worth $310K as of Q1 2026.
- Peapack-Gladstone Financial Corp bought 3 Biogen shares in Q1 2026, an estimated $553.
- Biogen made up ﹤0.01% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #576 holding.
- Peapack-Gladstone Financial Corp first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Peapack-Gladstone Financial Corp's Biogen position peaked at $1.3M in Q1 2015.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.